Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2025-12-24 @ 10:21 PM
NCT ID:
NCT06622135
Eligibility Criteria:
Inclusion Criteria:
* Subject with Alzheimer's Disease Only: diagnosed according the NIA-AA diagnostic AD criteria
* Healthy Control Only: Subject does not have history of cognitive impairment
* 55 - 90 years old
* Subject able to comply with study procedures
* Subjects must be able to use the Tasso device for blood sample collection as per the provided instructions (can be performed with the assistance of a caregiver)
* Subjects must be able to undergo IV sampling
* Have a study partner who will provide written informed consent to participate, and assist with blood collection when applicable
Exclusion Criteria:
* Subjects with systemic conditions which were not adequately controlled through a stable medication regimen
* Subjects with any known significant bleeding disorders or conditions that contraindicate blood sample collection (e.g., hemophilia, severe thrombocytopenia)
* Subjects with a known history of severe skin allergies or reactions to adhesives (since the Tasso device involves adhesive application to the skin)
* Subjects currently taking anticoagulant or antiplatelet medications that could interfere with blood collection or increase the risk of complications
* Subjects who have undergone major surgery or have been hospitalized for any reason in the last 3 months prior to study enrollment
* Participation in a clinical study within the 2 month
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
90 Years
Study:
NCT06622135
Study Brief:
Protocol Section:
NCT06622135